|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 17, 2018 ) Singapore: A global report titled Coronary Artery Disease Therapeutics Market has been introduced into our library of 2.5 million reports.
About the market report:
Coronary artery disease (CAD) is the most common type of heart disease and is one of the leading causes of death globally. It can lead to complications including myocardial infarction, stable angina, unstable angina, and sudden cardiac death. CAD is the narrowing of the coronary arteries that prevents the supply of an adequate amount of blood supply to the heart. It happens when a coronary artery gets hardened or narrowed due to various reasons such as the build-up of cholesterol or other materials known as plaque on the inner wall of the artery. This build-up is known as atherosclerosis. With passing time, a lesser amount of blood flows through the arteries. As a result heart muscle fails to get the required amount of blood or oxygen.
To access the full table of contents of the report click below: https://www.marketintelreports.com/report/tech1419/global-coronary-artery-disease-therapeutics-market-20172021
Scope of the Report:
This report focuses on the Coronary Artery Disease Therapeutics in global market, especially in Americas, APAC, EMEA. This report categorizes the market based on manufacturers, regions, types and applications.
Sample companies covered are:
• AstraZeneca
• Gilead
• Novartis
• Pfizer
To find out more of the report or request some customization : https://www.marketintelreports.com/inquiry-before-buying.php?id=tech1419
Table of Contents-Key Points Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
• Market outline
• Disease definition
• Risk factors for CAD
• Diagnosis
• Treatment options
PART 05: MARKET LANDSCAPE
• Market overview
………….
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Growing strategic alliances
Continued…..
Complete Report Details @ https://www.marketintelreports.com/report/tech1419/global-coronary-artery-disease-therapeutics-market-20172021
About us:
MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.
MarketIntelReports currently has more than 2.5 million titles and 200 publishers on our platform and are growing consistently to fill the “World Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
MarketIntelReports
Lakshmi
1-302-261-5343
sales@marketintelreports.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
